8 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... condition #IDSA ... Empiric #Coverage #InfectiousDiseases ... #Pharmacology # ... Management
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
#IDSA #Meningitis ... Pathogens #Isolated #InfectiousDiseases ... #Pharmacology # ... Management
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
virus causing COVID ... ivermectin… #COVID19 ... Pandemic #Outbreak #InfectiousDiseases ... EmergencyMedicine #Pharmacology ... Virus #Antiviral #Management
COVID-19 review…here is a list of some of the drugs that are currently being used or
COVID-19 review… ... investigated for COVID ... CoronaVirus #Treatment #Management ... Pandemic #Outbreak #InfectiousDiseases ... Pharmacotherapy #Pharmacology
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... infection Episode #Pharmacology ... #Management #CDiff
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
C.diff - Clostridioides ... Diagnosis and Management ... (IDSA 2021): ... ciab549 #CDI #Cdiff ... #treatment #infectiousdiseases
Azithromycin - since there has been a lot of noise around chloroquine/hydroxychloroquine, thought we can take
treatments for COVID ... Zithromax #Macrolides #InfectiousDiseases ... #COVID19 #Coronavirus ... #Treatment #Management ... #Pharmacology #
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
× 10 days #CDiff ... options #treatment #management ... #pharmacology # ... idsa #table